Qiqian
Liu
ae,
Hui
Liu
be,
Pasquale
Sacco
ce,
Nadia
Djaker
ae,
Marc
Lamy de la Chapelle
de,
Eleonora
Marsich
ce,
Xiaowu
Li
*be and
Jolanda
Spadavecchia
*ae
aCNRS, UMR 7244, NBD-CSPBAT, Laboratoire de Chimie, Structures et Propriétés de Biomatériaux et d’Agents Thérapeutiques Université Paris 13, Sorbonne Paris Nord, Bobigny, France. E-mail: jolanda.spadavecchia@univ-paris13.fr
bDepartment of Hepato-biliary Surgery, Shenzhen University General Hospital, Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Carson International Cancer, Shenzhen, 518055, China
cDepartment of Life Sciences, University of Trieste, Via L. Giorgieri 5, I-34127 Trieste, Italy
dDepartment of Medicine, Surgery and Health Sciences, University of Trieste, Piazzale Europa 1, I-34127 Trieste, Italy
eIMMM – UMR 6283 CNRS, Université du Mans, Avenue Olivier Messiaen, 72085 Le Mans, Cedex 9, France
First published on 14th October 2022
Correction for ‘CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model’ by Qiqian Liu et al., Nanoscale Adv., 2020, 2, 5231–5241. https://doi.org/10.1039/D0NA00758G.
The corrected version of Fig. 1 is shown below:
The authors also regret that there was an error in the first sentence below Fig. 1 of the original article. The text originally read: TEM images of DOX–AuGCs display a spherical shape and a narrow dispersion of the nanoparticle size with an average diameter of 50 ± 3 nm (Fig. 1A and A1).
This sentence should read: TEM images of DOX–AuGCs display a spherical shape and a relatively narrow dispersion of the nanoparticle size with an average diameter of 50 ± 30 nm (Fig. 1A and A1).
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2022 |